Bhakta Pradipta, Ghosh Bablu Rani, Singh Umesh, Govind Preeti S, Gupta Abhinav, Kapoor Kulwant Singh, Jain Rajesh Kumar, Nag Tulsi, Mitra Dipanwita, Ray Manjushree, Singh Vikash, Mukherjee Gauri
Department of Anesthesiology and Intensive Care, University Hospital Kerry, Tralee, Ireland.
Department of Anaesthesia and Intensive Care, Ramakrishna Mission Seva Pratishthan, Calcutta, India.
Acta Anaesthesiol Taiwan. 2016 Dec;54(4):108-113. doi: 10.1016/j.aat.2016.10.002. Epub 2016 Dec 23.
To determine the safety, efficacy, and feasibility of propofol-based anesthesia in gynecological laparoscopies in reducing incidences of postoperative nausea and vomiting compared to a standard anesthesia using thiopentone/isoflurane.
Randomized single-blind (for anesthesia techniques used) and double-blind (for postoperative assessment) controlled trial.
Operation theater, postanesthesia recovery room, teaching hospital.
Sixty ASA (American Society of Anesthesiologists) I and II female patients (aged 20-60 years) scheduled for gynecological laparoscopy were included in the study.
Patients in Group A received standard anesthesia with thiopentone for induction and maintenance with isoflurane-fentanyl, and those in Group B received propofol for induction and maintenance along with fentanyl. All patients received nitrous oxide, vecuronium, and neostigmine/glycopyrrolate. No patient received elective preemptive antiemetic, but patients did receive it after more than one episode of vomiting.
Assessment for incidence of postoperative nausea and vomiting as well as other recovery parameters were carried out over a period of 24 hours.
Six patients (20%) in Group A and seven patients (23.3%) in Group B experienced nausea. Two patients (6.66%) in Group B had vomiting versus 12 (40%) in Group A (p<0.05). Overall, the incidence of emesis was 60% and 30% in Groups A and B, respectively (p<0.05). All patients in Group B had significantly faster recovery compared with those in Group A. No patient had any overt cardiorespiratory complications.
Propofol-based anesthesia was associated with significantly less postoperative vomiting and faster recovery compared to standard anesthesia in patients undergoing gynecological laparoscopy.
与使用硫喷妥钠/异氟烷的标准麻醉相比,确定丙泊酚麻醉用于妇科腹腔镜手术在降低术后恶心和呕吐发生率方面的安全性、有效性和可行性。
随机单盲(针对所使用的麻醉技术)和双盲(针对术后评估)对照试验。
手术室、麻醉后恢复室、教学医院。
纳入60例计划进行妇科腹腔镜手术的美国麻醉医师协会(ASA)Ⅰ级和Ⅱ级女性患者(年龄20 - 60岁)。
A组患者采用硫喷妥钠进行诱导麻醉,异氟烷 - 芬太尼维持麻醉,B组患者采用丙泊酚进行诱导和维持麻醉,并同时使用芬太尼。所有患者均接受氧化亚氮、维库溴铵和新斯的明/格隆溴铵。没有患者接受选择性预防性止吐药,但在出现一次以上呕吐后患者会接受该药物治疗。
在24小时内对术后恶心和呕吐的发生率以及其他恢复参数进行评估。
A组有6例患者(20%)出现恶心,B组有7例患者(23.3%)出现恶心。B组有2例患者(6.66%)出现呕吐,而A组有12例患者(40%)出现呕吐(p<0.05)。总体而言,A组和B组的呕吐发生率分别为60%和30%(p<0.05)。与A组患者相比,B组所有患者的恢复明显更快。没有患者出现任何明显的心肺并发症。
与接受标准麻醉的妇科腹腔镜手术患者相比,丙泊酚麻醉术后呕吐明显减少,恢复更快。